Retaglutide is a novel GLP-1 receptor agonist currently under study for the control of obesity. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://sahilhtvl635513.ka-blogs.com/92196007/semaglutide-a-potential-solution-for-diabetes